HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,904,000 | +568.1% | 29,214 | +795.3% | 0.29% | +495.8% |
Q3 2020 | $285,000 | -2.1% | 3,263 | +29.0% | 0.05% | +41.2% |
Q4 2019 | $291,000 | -26.7% | 2,529 | -19.6% | 0.03% | -37.0% |
Q3 2019 | $397,000 | -48.8% | 3,147 | -64.5% | 0.05% | -31.6% |
Q1 2019 | $775,000 | -47.5% | 8,856 | -39.9% | 0.08% | -53.5% |
Q4 2018 | $1,475,000 | -20.1% | 14,745 | -8.5% | 0.17% | +66.7% |
Q3 2018 | $1,846,000 | -65.1% | 16,107 | -72.7% | 0.10% | -61.1% |
Q2 2018 | $5,286,000 | +518.2% | 58,941 | +404.3% | 0.26% | +482.2% |
Q1 2018 | $855,000 | -56.9% | 11,687 | -73.6% | 0.04% | -66.7% |
Q3 2017 | $1,984,000 | +442.1% | 44,210 | +377.6% | 0.14% | +462.5% |
Q2 2017 | $366,000 | -34.5% | 9,257 | -46.6% | 0.02% | -11.1% |
Q4 2015 | $559,000 | -25.6% | 17,326 | -25.4% | 0.03% | -27.0% |
Q3 2015 | $751,000 | +2.9% | 23,225 | +31.6% | 0.04% | +32.1% |
Q2 2015 | $730,000 | +3.4% | 17,654 | +12.3% | 0.03% | 0.0% |
Q1 2015 | $706,000 | +168.4% | 15,726 | +123.8% | 0.03% | +55.6% |
Q4 2014 | $263,000 | – | 7,026 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |